(S)-(2-aminopyridin-3-yl)(6-(3-isobutylpiperazin-1-yl)-3-(trifluoromethyl)pyridin-2-yl)methanone | 1042985-00-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (S)-(2-aminopyridin-3-yl)(6-(3-isobutylpiperazin-1-yl)-3-(trifluoromethyl)pyridin-2-yl)methanone
• 英文别名: (2-aminopyridin-3-yl)-[6-[(3S)-3-(2-methylpropyl)piperazin-1-yl]-3-(trifluoromethyl)pyridin-2-yl]methanone
• CAS: 1042985-00-1
• 化学式: C₂₀H₂₄F₃N₅O
• 分子量: 407.439
• InChiKey: XWKJUHBICAMYNW-ZDUSSCGKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  84.1
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  (S)-1-Boc-2-异丁基哌嗪 、 (2-aminopyridin-3-yl)(6-chloro-3-(trifluoromethyl)pyridin-2-yl)methanone 在 potassium carbonate 、 三氟乙酸 、 水 、 sodium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 二氯甲烷 为溶剂， 反应 3.83h， 以77%的产率得到(S)-(2-aminopyridin-3-yl)(6-(3-isobutylpiperazin-1-yl)-3-(trifluoromethyl)pyridin-2-yl)methanone
  参考文献：
  名称：

  WO2008/94992

  摘要：

  公开号：

文献信息

• KINASE INHIBITORS
  申请人：MALTAIS FRANCOIS

  公开号：US20090124602A1

  公开（公告）日：2009-05-14

  The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

  本发明涉及用作蛋白激酶抑制剂的化合物。该发明还提供了含有所述化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病、状况或障碍的方法。该发明还提供了制备本发明化合物的方法。
• Amino substituted pyridines as potent kinase inhibitors
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US08188071B2

  公开（公告）日：2012-05-29

  The present invention relates to compounds useful as inhibitors of protein kinase of the following structural formula: The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

  本发明涉及以下结构式的蛋白激酶抑制剂化合物，同时提供了包含所述化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病、病况或疾患的方法。本发明还提供了制备该发明化合物的方法。
• Kinase inhibitors
  申请人：Jimenez Juan-Miguel

  公开号：US08741931B2

  公开（公告）日：2014-06-03

  The present invention relates to compounds having formula: which are useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

  本发明涉及具有以下结构式的化合物：该化合物可用作蛋白激酶抑制剂。本发明还提供了包含上述化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病、状况或障碍的方法。本发明还提供了制备本发明化合物的方法。
• AMINOPYRIDINE KINASE INHIBITORS
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20130137703A1

  公开（公告）日：2013-05-30

  The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
• Stem Cell Modulation II
  申请人：UNIVERSITY OF CANBERRA

  公开号：US20160354367A1

  公开（公告）日：2016-12-08

  Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta inhibitors (PKC-θ) for inhibiting the growth of PKC-θ-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including metastatic cancer and/or for preventing cancer recurrence.